Psychological and Physiological Effects of MDMA ("Ecstasy") after Pretreatment with the 5-HT(2) Antagonist Ketanserin in Healthy Humans

by

Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX

University Hospital of Psychiatry Zurich,

P.O. Box 68, CH-8029, Zurich,

Switzerland

Neuropsychopharmacology 2000 Oct 1; 23(4): 396-404



ABSTRACT

MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") mainly releases serotonin and dopamine. In animals, pretreatment with 5-HT(2) antagonists has been shown to attenuate neurochemical and behavioral effects of MDMA. In humans, the role of 5-HT(2) receptors in the action of MDMA has not been studied. We investigated the effect of pretreatment with the 5-HT(2A/C) antagonist ketanserin (50 mg p.o.) on subjective responses to MDMA (1.5 mg/kg p.o.) in 14 healthy volunteers using a double-blind placebo-controlled within-subject design. Subjective effects were rated by psychometric rating scales. Physiological effects measured were blood pressure, heart rate, and body temperature. Adverse effects were assessed during the sessions, and after one and three days. Ketanserin attenuated MDMA-induced perceptual changes, emotional excitation, and acute adverse responses but had little effect on MDMA-induced positive mood, well-being, extroversion, and short-term sequelae. Body temperature was lower under MDMA plus ketanserin compared to MDMA alone. The results suggest a contributing role for 5-HT(2) receptors in the action of MDMA in humans.



Refs

and further reading

HOME

HedWeb

Nootropics

erythroxylum-coca.com

Future Opioids

BLTC Research

MDMA/Ecstasy

Superhapiness?

Utopian Surgery?

The Abolitionist Project

The Hedonistic Imperative

The Reproductive Revolution

Critique of Huxley's Brave New World





The Good Drug Guide

The Responsible Parent's Guide

To Healthy Mood Boosters For All The Family

